4 results
Primary:* To evalaute the efficacy of three doses of norUDCA vs. placebo for the treatment of PSC* To identify efficacious norUDCA dose(s) for the treatment of PSC for further evaluation in phase III. Secondary:* To study safety and tolerability (…
To explore the efficacy and safety of an oral IP receptor agonist in an inoperable or persistent/recurrent CTEPH population treated with standard of care.
The aim of the present study is to investigate whether selexipag could be helpful to treat patients with another form of PH called sarcoidosis-associated pulmonary hypertension (SAPH).
Main objective: Part A: To evaluate the safety and tolerability of AL102 in subjects withprogressing desmoid tumorsPart B: To evaluate effects of AL102 on disease progression in subjectswith progressing desmoid tumorsOLE: To evaluate the safety and…